Transferability of Economic Evaluations of Treatments for Advanced Melanoma

BACKGROUND: Differing methodological requirements and decision-making criteria are recognised as barriers to transferability of cost-effectiveness analysis (CEA) across jurisdictions. OBJECTIVE: We assessed the generic and specific transferability of published CEAs of systemic treatments for advance...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorry, Claire, McCullagh, Laura, Barry, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081651/
https://www.ncbi.nlm.nih.gov/pubmed/31761996
http://dx.doi.org/10.1007/s40273-019-00860-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081651/
https://www.ncbi.nlm.nih.gov/pubmed/31761996
http://dx.doi.org/10.1007/s40273-019-00860-y

Ejemplares similares